Clinical Trials Browser

Phase 1/2 × amivantamab × 90 days × Clear all

NCT05379595 2026-06-05

OrigAMI-1

Phase 1/2 Recruiting

Gastrointestinal

Colorectal Neoplasms

NCT05488314 2026-06-05

METalmark

Phase 1/2 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT05908734 2026-06-05

PolyDamas

Phase 1/2 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT06385080 2026-06-05

OrigAMI-4

Phase 1/2 Recruiting

Squamous Cell Carcinoma of Head and Neck

NCT07227025 2026-06-05

KaRAnaSa

Phase 1/2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT06532032 2026-04-13

swalloWTail

Phase 1/2 Active not recruiting

Carcinoma, Non-Small-Cell Lung